Back
Caleres, Inc. 10K Form
Sell
42
CAL
Caleres, Inc.
Last Price:
$13.16
Seasonality Move:
1.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-12-05 | 10Q | CAL/Caleres, Inc. Quarterly |
| 2023-09-05 | 10Q | CAL/Caleres, Inc. Quarterly |
| 2023-06-06 | 10Q | CAL/Caleres, Inc. Quarterly |
| 2022-12-06 | 10Q | CAL/Caleres, Inc. Quarterly |
| 2022-09-06 | 10Q | CAL/Caleres, Inc. Quarterly |
| 2022-06-07 | 10Q | CAL/Caleres, Inc. Quarterly |
Receive CAL News And Ratings
See the #1 stock for the next 7 days that we like better than CAL
CAL Financial Statistics
Sales & Book Value
| Annual Sales: | $2.7B |
|---|---|
| Cash Flow: | $-13.9M |
| Price / Cash Flow: | 38.2 |
| Annual Sales: | $18.19 |
| Price / Book: | 0.71 |
Profitability
| EPS (TTM): | 0.61920 |
|---|---|
| Net Income (TTM): | $17.6M |
| Gross Margin: | $1.2B |
| Return on Equity: | 2.86% |
| Return on Assets: | 0.86% |
Caleres, Inc. Earnings Forecast
Key Caleres, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for CAL is 44.29%.
-
The Selling, General & Administrative Expenses for CAL have been equal to 39.12% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 13.65% of Operating Income.
-
The Net Earning history of CAL is 3.76% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 18 years.
Caleres, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Specialty Retail |
| Sector: | Consumer Discretionary |
| Current Symbol: | CAL |
| CUSIP: | 129500 |
| Website: | caleres.com |
Debt
| Debt-to-Equity Ratio: | 1.56 |
|---|---|
| Current Ratio: | 1.06 |
| Quick Ratio: | 0.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.17 |
|---|---|
| Forward P/E Ratio: | 7.71 |
CAL Technical Analysis vs Fundamental Analysis
Sell
42
Caleres, Inc. (CAL)
is a Sell
Is Caleres, Inc. a Buy or a Sell?
-
Caleres, Inc. stock is rated a SellThe current Caleres, Inc. [CAL] share price is $13.30. The Score for CAL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.